As of 2025-07-04, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (5.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -742.5%.
The range of the Relative Valuation is (3.41) - (7.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 18.6x | 13.1x |
| Forward P/E multiples | 8.2x - 21.2x | 13.7x |
| Fair Price | (3.41) - (7.73) | (5.56) |
| Upside | -494.1% - -992.8% | -742.5% |
| Date | P/E |